Suprachoroidal Triamcinolone Acetonide Injection in Two Chorioretinal Diseases: One Year Results
试验速览
- 阶段
- 2 期
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Central macular thickness
研究概览
简要总结
Suprachoroidal injection is a safe way for intraocular drug delivery. It was used to treat various retinal conditions.
详细描述
Suprachoroidal triamcinolone acetonide injection is used to treat various retinal diseases, higher concentration of the injected material is found when the suprachoroidal space is used as an intraocular delivery pathway when compared to the conventional intravitreal pathway.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients diagnosed as central serous chorioretinopathy and patients with cystoid macular edema due to irvine-gass syndrome after cataract surgery.
排除标准
- •other retinal diseases that may affect CMT and final visual outcome.
- •Patients with dense corneal opacity.
研究组 & 干预措施
Central serous chorioretinopathy group
Cases with central serous chorioretinopathy (CSR) that will be injected with suprachoroidal triamcinolone acetonide.
干预措施: Triamcinolone Acetonide (Drug)
Irvine-Gass Syndrome group
Cases with cystoid macular edema due to irvine-gass syndrome that will be injected with suprachoroidal triamcinolone acetonide
干预措施: Triamcinolone Acetonide (Drug)
结局指标
主要结局
Central macular thickness
时间窗: Baseline and 12 months after injection.
Changes in central macular thickness (CMT) measured in millimeters (mm) by optical coherence tomography (OCT)
次要结局
- Best corrected visual acuity(Baseline and 12 months after injection.)
研究者
Ahmed Abdelshafy
Assistant professor of Ophthalmology
Benha University